title: Bullae and psoriasiform hyperkeratosis after treatment with golimumab.
authors.forename: Lauren M
authors.initials: LM
authors.lastname: Madigan
authors.forename: Benjamin H
authors.initials: BH
authors.lastname: Kaffenberger
authors.forename: Henry K
authors.initials: HK
authors.lastname: Wong
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001768:Blister / Q000139:chemically induced*; D003875:Drug Eruptions / Q000209:etiology*; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D053546:Keratoderma, Palmoplantar, Epidermolytic / Q000139:chemically induced*; D008875:Middle Aged; D025242:Spondylarthropathies / Q000188:drug therapy; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D014409:Tumor Necrosis Factor-alpha; C529000:golimumab